The role of exercise in modifying outcomes for people with multiple sclerosis: A randomized trial

BMC Neurology

Volumn 13, Issue , 2013, Pages

  Mayo, Nancy E ^a   Bayley, Mark ^b   Duquette, Pierre ^c   Lapierre, Yves ^d   Anderson, Ross ^e   Bartlett, Susan ^a  

^a ROYAL VICTORIA HOSPITAL   (Canada)

^b TORONTO REHABILITATION INSTITUTE   (Canada)

^c CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MCGILL UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOPYRIDINE;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; EXERCISE; FATIGUE; FEMALE; FOLLOW UP; HUMAN; INTENTION TO TREAT ANALYSIS; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; MOOD; MULTIPLE SCLEROSIS; MUSCLE STRENGTH; OUTCOMES RESEARCH; PERCEPTION; PILOT STUDY; PRACTICE GUIDELINE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEDENTARY LIFESTYLE; SELF CARE; SINGLE BLIND PROCEDURE;

ADULT; AGED; DOUBLE-BLIND METHOD; EXERCISE THERAPY; FATIGUE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIPLE SCLEROSIS; QUALITY OF LIFE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84879438948     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-13-69     Document Type: Article

References (95)

1. Warren S, Warren KG. Prevalence, incidence, and characteristics of multiple sclerosis in Westlock County, Alberta, Canada. Neurology 1993, 43:1760-1763. 10.1212/WNL.43.9.1760, 8414027.
2. Warren S, Warren KG. Prevalence of multiple sclerosis in Barrhead county, Alberta, Canada. Can J Neurol Sci 1992, 19:72-75.
3. Warren S, Warren KG, Svenson LW, Schopflocher DP, Jones A. Geographic and temporal distribution of mortality rates for multiple sclerosis in Canada, 1965-1994. Neuroepidemiology 2003, 22:75-81. 10.1159/000067111, 12566957.
4. Warren S, Svenson LW, Warren KG, Metz LM, Patten SB, Schopflocher DP. Incidence of multiple sclerosis among First Nations people in Alberta, Canada. Neuroepidemiology 2007, 29:21-27.
5. Turner AP, Kivlahan DR, Haselkorn JK. Exercise and quality of life among people with multiple sclerosis: looking beyond physical functioning to mental health and participation in life. Arch Phys Med Rehabil 2009, 90:420-428. 10.1016/j.apmr.2008.09.558, 19254606.
6. Multiple Sclerosis Society of Canada Multiple Sclerosis Society of Canada 2009, Canada: MS Society of Canada, http://www.mssociety.ca, Multiple Sclerosis Society of Canada.
7. Patwardhan MB, Matchar DB, Samsa GP, McCrory DC, Williams RG, Li TT. Cost of multiple sclerosis by level of disability: a review of literature. Mult Scler 2005, 11:232-239. 10.1191/1352458505ms1137oa, 15794399.
8. Stuv O, Oksenberg J. Multiple Sclerosis Overview. GENE Reviews 2006, 1-10.
9. Kesselring J, Beer S. Rehabilitation in Multiple Sclerosis. Advances in Clinical Neuroscience and Rehabilitation 2002, 2:6-8.
10. Kantarci O, Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Curr Opin Neurol 2006, 19:248-254. 10.1097/01.wco.0000227033.47458.82, 16702830.
11. Kantarci OH, Weinshenker BG. Natural history of multiple sclerosis. Neurol Clin 2005, 23:17-38. 10.1016/j.ncl.2004.10.002, 15661086.
12. White LJ, Castellano V. Exercise and brain health-implications for multiple sclerosis: Part 1-neuronal growth factors. Sports Med 2008, 38:91-100. 10.2165/00007256-200838020-00001, 18201113.
13. White LJ, Castellano V. Exercise and brain health-implications for multiple sclerosis: Part II-immune factors and stress hormones. Sports Med 2008, 38:179-186. 10.2165/00007256-200838030-00001, 18278981.
14. Dalgas U, Stenager E, Ingemann-Hansen T. Multiple sclerosis and physical exercise: recommendations for the application of resistance-, endurance- and combined training. Mult Scler 2008, 14:35-53. 10.1177/1352458507079445, 17881393.
15. Mayo N. Setting the agenda for multiple sclerosis rehabilitation research. Mult Scler 2008, 14:1154-1156. 10.1177/1352458508096567, 18952830.
16. Motl RW, Snook EM, McAuley E, Scott JA, Douglass ML. Correlates of physical activity among individuals with multiple sclerosis. Ann Behav Med 2006, 32:154-161. 10.1207/s15324796abm3202_13, 16972813.
17. Motl RW, Snook EM, McAuley E, Gliottoni RC. Symptoms, self-efficacy, and physical activity among individuals with multiple sclerosis. Res Nurs Health 2006, 29:597-606. 10.1002/nur.20161, 17131278.
18. American College of Sports Medicine ACSM's Resource Manual for Guidelines for Exercise Testing and Prescription, 6th edition edn 2010, Baltimore, MD: Lippincott Williams & Wilkins, American College of Sports Medicine.
19. Motl RW, McAuley E, Snook EM, Motl RW, McAuley E, Snook EM. Physical activity and multiple sclerosis: a meta-analysis. Mult Scler 2005, 11:459-463. 10.1191/1352458505ms1188oa, 16042230.
20. Rietberg MB, Brooks D, Uitdehaag BM, Kwakkel G. Exercise therapy for multiple sclerosis. Cochrane Database Syst Rev 2005, CD003980.
21. Asano M, Dawes D, Arafah A, Moriello C, Mayo N. What does a structured review of the effectiveness of exercise interventions for persons with multiple sclerosis tell us about the challenges of designing trials?. Mult Scler 2009, 15:412-421.
22. Stuifbergen AK. Physical activity and perceived health status in persons with multiple sclerosis. J Neurosci Nurs 1997, 29:238-243. 10.1097/01376517-199708000-00004, 9307926.
23. Dalgas U, Stenager E, Jakobsen J, Petersen T, Hansen HJ, Knudsen C, et al. Resistance training improves muscle strength and functional capacity in multiple sclerosis. Neurology 2009, 73:1478-1484. 10.1212/WNL.0b013e3181bf98b4, 19884575.
24. Khan F, Pallant JF, Brand C, Kilpatrick TJ. Effectiveness of rehabilitation intervention in persons with multiple sclerosis: a randomised controlled trial. J Neurol Neurosurg Psychiatry 2008, 79:1230-1235. 10.1136/jnnp.2007.133777, 18535027.
25. Dettmers C, Sulzmann M, Ruchay-Plossl A, Gutler R, Vieten M. Endurance exercise improves walking distance in MS patients with fatigue. Acta Neurol Scand 2009, 120:251-257. 10.1111/j.1600-0404.2008.01152.x, 19178385.
26. Plow MA, Mathiowetz V, Lowe DA. Comparing individualized rehabilitation to a group wellness intervention for persons with multiple sclerosis. Am J Health Promot 2009, 24:23-26. 10.4278/ajhp.071211128, 19750959.
27. Collett J, Dawes H, Meaney A, Sackley C, Barker K, Wade D, et al. Exercise for multiple sclerosis: a single-blind randomized trial comparing three exercise intensities. Mult Scler 2011, 17:594-603. 10.1177/1352458510391836, 21247971.
28. Castro-Sanchez AM, Mataran-Penarrocha GA, Lara-Palomo I, Saavedra-Hernandez M, Arroyo-Morales M, Moreno-Lorenzo C. Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evid Based Complement Alternat Med 2012, 201(2):473963.
29. Chang YJ, Hsu MJ, Chen SM, Lin CH, Wong AM. Decreased central fatigue in multiple sclerosis patients after 8 weeks of surface functional electrical stimulation. J Rehabil Res Dev 2011, 48:555-564. 10.1682/JRRD.2010.03.0038, 21674405.
30. Hayes HA, Gappmaier E, LaStayo PC. Effects of high-intensity resistance training on strength, mobility, balance, and fatigue in individuals with multiple sclerosis: a randomized controlled trial. J Neurol Phys Ther 2011, 35:2-10. 10.1097/NPT.0b013e31820b5a9d, 21475078.
31. Hebert JR, Corboy JR, Manago MM, Schenkman M. Effects of vestibular rehabilitation on multiple sclerosis-related fatigue and upright postural control: a randomized controlled trial. Phys Ther 2011, 91:1166-1183. 10.2522/ptj.20100399, 21680771.
32. Rampello A, Franceschini M, Piepoli M, Antenucci R, Lenti G, Olivieri D, et al. Effect of aerobic training on walking capacity and maximal exercise tolerance in patients with multiple sclerosis: a randomized crossover controlled study. Phys Ther 2007, 87:545-555. 10.2522/ptj.20060085, 17405806.
33. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Ann Neurol 1996, 39:432-441. 10.1002/ana.410390405, 8619521.
34. De Souza-Teixeira F, Costilla S, Ayan C, Garcia-Lopez D, Gonzalez-Gallego J, De Paz JA. Effects of resistance training in multiple sclerosis. Int J Sports Med 2009, 30:245-250. 10.1055/s-0028-1105944, 19199197.
35. Lucio AC, Campos RM, Perissinotto MC, Miyaoka R, Damasceno BP, D'ancona CA. Pelvic floor muscle training in the treatment of lower urinary tract dysfunction in women with multiple sclerosis. Neurourol Urodyn 2010, 29:1410-1413. 10.1002/nau.20941, 20976816.
36. McClurg D, Lowe-Strong A, Ashe R. Pelvic floor training for lower urinary tract dysfunction in MS. Nurs Times 2009, 105:45-47.
37. McClurg D, Ashe RG, Marshall K, Lowe-Strong AS. Comparison of pelvic floor muscle training, electromyography biofeedback, and neuromuscular electrical stimulation for bladder dysfunction in people with multiple sclerosis: a randomized pilot study. Neurourol Urodyn 2006, 25:337-348. 10.1002/nau.20209, 16637070.
38. DeRidder D, Vermeulen C, Ketelaer P, Van PH, Baert L. Pelvic floor rehabilitation in multiple sclerosis. Acta Neurol Belg 1999, 99:61-64.
39. White LJ, Dressendorfer RH, White LJ, Dressendorfer RH. Exercise and multiple sclerosis. Sports Med 2004, 34:1077-1100. 10.2165/00007256-200434150-00005, 15575796.
40. American College of Sports Medicine Musculoskeltal, Neuromuscular, Neoplastic, Immunologic, and Hematologic Conditions. ACSM's Resources for Clinical Exercise Physiology 2002, Baltimore, MD: Lippincot Williams & Wilkins, Myers JN, Herbert WG, Humphrey R, American College of Sports Medicine.
41. Johnston K, Carlye L, Rattray S. MS Active Now: Understanding MS and Exercise 2008, Alberta Division: Multiple Sclerosis Society of Canada.
42. American College of Sports Medicine ACSM's Resources for Clinical Exercise Physiology: Musculoskeltal, Neuromuscular, Neoplastic, Immunologic, and Hematologic Conditions, Second edition edn 2010, Baltimore, MD: Lippincott Williams & Wilkins, American College of Sports Medicine.
43. Canadian Society for Exercise Physiology Canadian Physical Activity Guidelines for Adults with Multiple Sclerosis 2013, http://www.csep.ca/CMFiles/Guidelines/specialpops/CSEP_MS_PAGuidelines_adults_en.pdf, Canadian Society for Exercise Physiology.
44. Asano M, Duquette P, Andersen R, Lapierre Y, Mayo NE. Exercise barriers and preferences among women and men with multiple sclerosis. Disabil Rehabil 2013, 35:353-361. 10.3109/09638288.2012.742574, 23347461.
45. Zifko UA. Management of fatigue in patients with multiple sclerosis. Drugs 2004, 64.
46. Kuspinar A, Andersen R, Mayo NE. Predicting Exercise Capacity through Sub-Maximal Fitness Testing in Persons with Multiple Sclerosis. Arch Phys Med Rehabil 2010, 91:1410-1417. 10.1016/j.apmr.2010.06.005, 20801260.
47. Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 2011, 69:292-302. 10.1002/ana.22366, 3084507, 21387374.
48. Varga J, Porszasz J, Boda K, Casaburi R, Somfay A. Supervised high intensity continuous and interval training vs. self-paced training in COPD. Respir Med 2007, 101:2297-2304. 10.1016/j.rmed.2007.06.017, 17689948.
49. Tjonna AE, Lee SJ, Rognmo O, Stolen TO, Bye A, Haram PM, et al. Aerobic interval training versus continuous moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 2008, 118:346-354. 10.1161/CIRCULATIONAHA.108.772822, 2777731, 18606913.
50. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970, 2:92-98.
51. Wade DT. Goal setting in rehabilitation: an overview of what, why and how. Clin Rehabil 2009, 23:291-295. 10.1177/0269215509103551, 19293289.
52. Bovend'Eerdt TJ, Botell RE, Wade DT. Writing SMART rehabilitation goals and achieving goal attainment scaling: a practical guide. Clin Rehabil 2009, 23:352-361. 10.1177/0269215508101741, 19237435.
53. Knauper B, McCollam A, Rosen-Brown A, Lacaille J, Kelso E, Roseman M. Fruitful plans: adding targeted mental imagery to implementation intentions increases fruit consumption. Psychol Health 2011, 26:601-617. 10.1080/08870441003703218, 21337259.
54. Gollwitzer PM. Implementation intentions: Strong effects of simple plans. Am Psychol 1999, 54:493-503.
55. Schulz KH, Gold SM, Witte J, Bartsch K, Lang UE, Hellweg R, et al. Impact of aerobic training on immune-endocrine parameters, neurotrophic factors, quality of life and coordinative function in multiple sclerosis. J Neurol Sci 2004, 225:11-18. 10.1016/j.jns.2004.06.009, 15465080.
56. Bjarnadottir OH, Konradsdottir AD, Reynisdottir K, Olafsson E. Multiple sclerosis and brief moderate exercise. A randomised study. Mult Scler 2007, 13:776-782. 10.1177/1352458506073780, 17613606.
57. Gaesser GA, Brooks GA. Muscular efficiency during steady-rate exercise: effects of speed and work rate. J Appl Physiol 1975, 38:1132-1139.
58. Woo JS, Derleth C, Stratton JR, Levy WC. The influence of age, gender, and training on exercise efficiency. J Am Coll Cardiol 2006, 47:1049-1057. 10.1016/j.jacc.2005.09.066, 16516092.
59. Weller IMR, Thomas SG, Corey PN, Cox MH. Prediction of maximal oxygen uptake from a modified canadian aerobic fitness test. Can J Appl Physiol 1993, 18:175-188. 10.1139/h93-014, 8513290.
60. Goldman MD, Marrie RA, Cohen JA. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler 2008, 14:383-390. 10.1177/1352458507082607, 17942508.
61. Finch E, Brooks D, Stratford PW, Mayo NE. Physical rehabilitation outcome measures 2002, Hamilton: BC Decker Inc., 2.
62. Van den BM, Dawes H, Wade DT, Newman M, Burridge J, Izadi H, et al. Treadmill training for individuals with multiple sclerosis: a pilot randomised trial. J Neurol Neurosurg Psychiatry 2006, 77:531-533. 10.1136/jnnp.2005.064410, 2077516, 16543538.
63. Salbach NM, Mayo NE, Wood-Dauphinee S, Hanley JA, Richards CL, Cote R. A task-orientated intervention enhances walking distance and speed in the first year post stroke: a randomized controlled trial. Clin Rehabil 2004, 18:509-519. 10.1191/0269215504cr763oa, 15293485.
64. Garber CE, Friedman JH. Effects of fatigue on physical activity and function in patients with Parkinson's disease. Neurology 2003, 60:1119-1124. 10.1212/01.WNL.0000055868.06222.AB, 12682317.
65. Paltamaa J, Sarasoja T, Wikstrom J, Malkia E. Physical functioning in multiple sclerosis: a population-based study in central Finland. J Rehabil Med 2006, 38:339-345. 10.1080/16501970600731537, 17067966.
66. Meads DM, Doward LC, McKenna SP, Fisk J, Twiss J, Eckert B. The development and validation of the Unidimensional Fatigue Impact Scale (U-FIS). Mult Scler 2009, 15:1228-1238. 10.1177/1352458509106714, 19556314.
67. Gottschalk M, Kumpfel T, Flachenecker P, Uhr M, Trenkwalder C, Holsboer F, et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol 2005, 62:277-280. 10.1001/archneur.62.2.277, 15710856.
68. Hays RD, Sherbourne CD, Mazel RM. The RAND 36-Item Health Survey 1.0. Health Econ 1993, 2:217-227. 10.1002/hec.4730020305, 8275167.
69. Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med 2001, 33:350-357. 10.3109/07853890109002089, 11491194.
70. Brooks R. EuroQol: the current state of play. Health Policy 1996, 37:53-72. 10.1016/0168-8510(96)00822-6, 10158943.
71. Hurst NP, Kind P, Ruta D, Hunter M, Stubbings A. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). Br J Rheumatol 1997, 36:551-559. 10.1093/rheumatology/36.5.551, 9189057.
72. Myers C, Wilks D. Comparison of Euroqol EQ-5D and SF-36 in patients with chronic fatigue syndrome. Qual Life Res 1999, 8:9-16.
73. Dorman P, Slattery J, Farrell B, Dennis M, Sandercock P. Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. United Kingdom Collaborators in the International Stroke Trial. Stroke 1998, 29:63-68. 10.1161/01.STR.29.1.63, 9445330.
74. Ruta DA, Garratt AM, Leng M, Russell IT, MacDonald LM. A new approach to the measurement of quality of life. The Patient-Generated Index. Med Care 1994, 32:1109-1126.
75. Ruta DA, Garratt AM, Russell IT. Patient centred assessment of quality of life for patients with four common conditions. Qual Health Care 1999, 8:22-29. 10.1136/qshc.8.1.22, 2483625, 10557665.
76. Hohol MJ, Orav EJ, Weiner HL. Disease steps in multiple sclerosis: a longitudinal study comparing disease steps and EDSS to evaluate disease progression. Mult Scler 1999, 5:349-354.
77. Godfrey A, Culhane KM, Lyons GM. Comparison of the performance of the activPAL Professional physical activity logger to a discrete accelerometer-based activity monitor. Med Eng Phys 2007, 29:930-934. 10.1016/j.medengphy.2006.10.001, 17134934.
78. Lorig K, Stewart A, Ritter P, Gonzalez V, Laurent D, Lynch J. Outcome Measures for Health Education and other health Care Interventions 1996, Thousand Oaks: SAGE.
79. Sechrist KR, Walker SN, Pender NJ. Development and psychometric evaluation of the exercise benefits/barriers scale. Res Nurs Health 1987, 10:357-365. 10.1002/nur.4770100603, 3423307.
80. Franckowiak SC, Dobrosielski DA, Reilley SM, Walston JD, Andersen RE. Maximal heart rate prediction in adults that are overweight or obese. J Strength Cond Res 2011, 25:1407-1412. 10.1519/JSC.0b013e3181d682d2, 3081386, 21116203.
81. Larson EB, Burnison DS, Brown WS, Larson EB, Burnison DS, Brown WS. Callosal function in multiple sclerosis: bimanual motor coordination. Cortex 2002, 38:201-214. 10.1016/S0010-9452(08)70650-6, 12056689.
82. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003, 41:582-592.
83. Hayes KC. Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis. Neuropsychiatr Dis Treat 2011, 7:229-239. 3090287, 21573085.
84. Henney HR, Blight AR. Walking impairment in patients with multiple sclerosis - a new therapeutic approach and clinical potential of dalfampridine extended release tablets. Degenerative Neurological and Neuromuscular Disease 2012, 2:53-64.
85. Bagiella E. Clinical trials in rehabilitation: single or multiple outcomes?. Arch Phys Med Rehabil 2009, 90:S17-S21. 10.1016/j.apmr.2009.08.133, 19892070.
86. Mayo NE. Understanding Analyses of Randomized Trials. Medical Uses of Statistics 2009, 195-237. Hoboken, New Jersey: A John Wiley & Sons, Inc & The New England Journal of Medicine, Bailar JC, Hoaglin DC, 3.
87. Rubin DB. The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med 2007, 26:20-36. 10.1002/sim.2739, 17072897.
88. Rosenbaum PR, Rubin DB. Reducing Bias in Observational Studies Using Subclassification on the Propensity Score. J Am Stat Assoc 1984, 79:516-524.
89. Groenwold RH, Hak E, Hoes AW. Quantitative assessment of unobserved confounding is mandatory in nonrandomized intervention studies. J Clin Epidemiol 2009, 62:22-28. 10.1016/j.jclinepi.2008.02.011, 18619797.
90. Allison PD. Missing Data 2002, Thousand Oaks, California: Sage Publications, Inc.
91. Little R, Rubin D. Statistical Analysis with Missing Data 2002, John Wiley: New York, 2.
92. University of Missouri MyActivity Pyramid for Adults 2013, 18-64. http://extension.missouri.edu/p/n388, University of Missouri.
93. Weeks DL, Noteboom JT. Using the number needed to treat in clinical practice. Arch Phys Med Rehabil 2004, 85:1729-1731. 10.1016/j.apmr.2004.03.025, 15468039.
94. Sox HC, Goodman SN. The methods of comparative effectiveness research. Annu Rev Public Health 2012, 33:425-445. 10.1146/annurev-publhealth-031811-124610, 22224891.
95. Mayo NE, Scott S. Evaluating a complex intervention with a single outcome may not be a good idea: an example from a randomised trial of stroke case management. Age Ageing 2011, 40:718-724. 10.1093/ageing/afr061, 22016344.